Keynote Speaker |
| Professor Jesse Hoey University of Waterloo, Canada Dr. Jesse Hoey is a professor in the David R. Cheriton School of Computer Science at the University of Waterloo, where he leads the Computational Health Informatics Laboratory (CHIL). He is a Faculty Affiliate at the Vector Institute in Toronto. Dr. Hoey holds a Ph.D degree (2004) in computer science from the University of British Columbia. He has published over one hundred peer reviewed scientific papers. His primary research interest is to understand the nature of human emotional intelligence by attempting to build computational models of some of its core functions, and to apply them in domains with social and economic impact. He is Editor-in-Chief of the IEEE Transactions on Affective Computing and an Area Chair for the International Joint Conferences on Artificial Intelligence (IJCAI 2021). |
Keynote Speaker |
| Professor Riki Matsumoto Kyoto University, Japan Since 2018, Riki Matsumoto has been a professor at the Department of Neurology, Graduate School of Medicine, Kobe University. As the last bastion in Hyogo Prefecture, we provide comprehensive medical services ranging from common conditions like stroke, dementia, and epilepsy to stubborn neurological disorders. Serving as the director of both the Epilepsy Center and the Dementia Center, we have built an interdisciplinary healthcare system. In terms of research, besides joint studies with Japan and France in specialized systems brain physiology, I also have opportunities for interdisciplinary research both within and outside the university, as well as collaborative research and development of ultra-compact EEG devices with industry, academia, and government. Focusing on immune system and synaptic transformation (neuronal hyperexcitability) in the early stages of dementia, we are conducting pre-disease pathological marker and therapeutic intervention studies by integrating molecular genetics, immunology, pathology, physiology, and mathematics from cell culture and animal models to pre-disease cohorts. |
Keynote Speaker (TBD) |
|